Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
This research study is a multicentre phase Ⅰb/Ⅱ Study to evaluate the efficacy and safety of
SHR-A1921 in combination with other anti-cancer agents in patients with advanced solid tumors